Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
QuintilesIMS
Mallinckrodt
AstraZeneca
Chubb
Cipla
Merck
Deloitte
Baxter

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,374,747

« Back to Dashboard

Which drugs does patent 7,374,747 protect, and when does it expire?

Patent 7,374,747 protects EVOCLIN and is included in one NDA.

This patent has thirty patent family members in fifteen countries.
Summary for Patent: 7,374,747
Title:Pharmaceutical foam
Abstract:The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized contained comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.
Inventor(s): Abram; Albert Zorko (Wantirna, AU), Hunt; Barry Thomas (Carnegie, AU)
Assignee: Stiefel Research Australia, Pty Ltd. (Rowville, AU)
Application Number:11/463,573
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 7,374,747

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mylan Pharms Inc EVOCLIN clindamycin phosphate AEROSOL, FOAM;TOPICAL 050801-001 Oct 22, 2004 AT RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF ACNE VULGARIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,374,747

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,141,237 Pharmaceutical foam ➤ Sign Up
9,486,394 Pharmaceutical foam ➤ Sign Up
7,749,488 Pharmaceutical foam ➤ Sign Up
8,586,008 Pharmaceutical foam ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,374,747

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan I388322 ➤ Sign Up
Taiwan 201043230 ➤ Sign Up
Taiwan I355267 ➤ Sign Up
Taiwan 200420303 ➤ Sign Up
Serbia 20050557 ➤ Sign Up
New Zealand 541526 ➤ Sign Up
Norway 339620 ➤ Sign Up
Norway 20053577 ➤ Sign Up
Mexico PA05007722 ➤ Sign Up
Japan 5480201 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKinsey
US Army
UBS
Medtronic
Deloitte
Cerilliant
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot